Ted Lain, MD, MBA: Long-Term Results of Deuruxolitinib for Alopecia Areata episode artwork

EPISODE · Mar 17, 2026 · 7 MIN

Ted Lain, MD, MBA: Long-Term Results of Deuruxolitinib for Alopecia Areata

from The Journal of Clinical and Aesthetic Dermatology · host Matrix Medical Communications

Send us Fan MailTed Lain, MD, a board-certified dermatologist at Sanova Dermatology in Austin, Texas, shares his extensive experience with deuruxolitinib (Leqselvi) for the treatment of patients with moderate-to-severe alopecia areata. Drawing on 5 years of long-term extension data, Dr. Lain explains that patients generally maintained hair regrowth they achieved early in treatment, with no loss of effect over time. He emphasizes that this durability is crucial, as patients are often most afraid of losing newly regrown hair.

Episode metadata supplied by the publisher feed · Published Mar 17, 2026

Embed this episode

Ready to play

Ted Lain, MD, MBA: Long-Term Results of Deuruxolitinib for Alopecia Areata

0:00 7:51

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Journal of Clinical and Aesthetic Dermatology?

This episode is 7 minutes long.

When was this The Journal of Clinical and Aesthetic Dermatology episode published?

This episode was published on March 17, 2026.

Can I download this The Journal of Clinical and Aesthetic Dermatology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!